
|Videos|October 11, 2016
Atopic Dermatitis: Reimbursement Challenges
Advertisement
Panelists Peter L. Salgo, MD; Ed Pezalla, MD, MPH; Jeffrey D. Dunn, PharmD, MBA; Cheryl Allen, BS Pharm, MBA; and Jonathan Silverberg, MD, PhD, MPH, outline translating clinical trial results and some of the reimbursement challenges when treating patients with atopic dermatitis.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
TrumpRx Launches, Offering Cash-Paying Patients Discounted Drugs
2
Pharmacist Takeover: CAR T Therapy Signals a Shift in ALL Treatment
3
SGLT2 Inhibitors in T2D Lower 5-Year Risk of CKD and Acute Kidney Injury
4
Q&A: How Pharmacists Can Address Structural Barriers in Obesity Care
5


























